To mark Daffodil Day, we chat to a cancer survivor to learn what living with cancer is like – Emma Butler was diagnosed with a rare form of cancer that usually affects older men ...

Size-exclusion chromatography (SEC) was used to purify extracellular vesicles (EVs) from the plasma of chronic myeloid leukemia (CML) patients to evaluate treatment responses and mutation statuses.

Specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO) has announced the publication 1 in the Journal of Clinical Pathology of a study conducted in collaboration with the Memorial ...

Global health has undergone historic transformation. The burden of infectious diseases has steadily declined, whereas noncommunicable diseases have become increasingly significant, even in ...

Leukemic ocular involvement arises from direct infiltration, hematologic derangements (anemia, thrombocytopenia, hyperviscosity), opportunistic infections, or drug toxicity, and may be the first ...

Data Trends provide quick, visually memorable data-driven information and insights that are useful in clinical practice. Here, we explore recent treatment updates in chronic lymphocytic leukemia (CLL) ...

For years, scientists have been working to unravel the mystery of patients with failing kidneys dying from heart-related complications. Researchers now say they’ve uncovered a clue that explains why ...

Deaths from both causes are down, but they still eclipse all other causes, according to new statistics. By Nina Agrawal Despite gains in treatment, cardiovascular disease remains the leading cause of ...

ABSTRACT: Introduction: The coexistence of chronic myeloid leukemia and Hodgkin lymphoma (HL) is rare. In the few reported cases, HL occurs after a varying duration of treatment with tyrosine kinase ...

CLEVELAND, Ohio — Chronic disease could cost the United States as much as $47 trillion between 2024 and 2039, including $2.2 trillion annually in medical costs and nearly $900 billion each year in ...

The MarketWatch News Department was not involved in the creation of this content. 64% MMR achievement by 24 weeks across all efficacy evaluable patients 75% MMR achievement by 24 weeks in efficacy ...

Company to host investor update call today at 4:30pm ET FOSTER CITY, Calif., Dec. 08, 2025 (GLOBE NEWSWIRE) -- Terns Pharmaceuticals, Inc. (Terns or the Company) (Nasdaq: TERN), a clinical-stage ...